Fig. 4From: Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancerReceiver operating characteristic curve showing Ki-67 as a predictor of Recurrence Score® result for all samples with confirmed N1 status (n = 298). n, sample size; N1, 1–3 positive lymph nodesBack to article page